CPT 40490 Biopsy of Lip Reimbursement Benchmarks | OpenPayer

Summary & Overview

CPT 40490: Biopsy of Lip, Surgical Excision Procedure

CPT code 40490 is a nationally recognized billing code for the biopsy of the lip, a surgical procedure performed to obtain tissue samples for diagnostic evaluation. This procedure is commonly used to assess lesions, masses, or other abnormalities of the lip, helping clinicians determine the presence of benign or malignant conditions. The code is most frequently utilized in office settings, reflecting its routine use in outpatient care.

Major payers covering this procedure include Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare. The publication provides a comprehensive overview of payer coverage, policy updates, and clinical benchmarks relevant to 40490. Readers will gain insight into the procedural context, typical clinical indications, and billing considerations, including common modifiers and associated taxonomies. The summary also highlights related CPT codes and ICD-10 diagnoses that are frequently linked to lip biopsy procedures.

This article is designed to inform healthcare professionals, billing specialists, and policy analysts about the current landscape for 40490, including payer policies, clinical context, and coding practices. The information supports accurate billing and documentation, ensuring compliance with national standards and facilitating appropriate reimbursement for lip biopsy services.

AetnaBlue Cross Blue ShieldCigna HealthMedicareUnitedHealthcareCPT 40490biopsylip surgeryexcision proceduresoffice proceduressurgical codingclinical benchmarkspolicy updatesICD-10 diagnosesmodifier codes

CPT Code Overview

CPT code 40490 represents a biopsy of the lip, a surgical procedure classified under excision procedures on the lips. This code is used when a physician removes a sample of tissue from the lip for diagnostic purposes, such as evaluating lesions or abnormalities. The procedure is typically performed in an office setting (Place of Service 11). Biopsies of the lip are essential for diagnosing a range of conditions, including neoplastic and non-neoplastic diseases, and play a critical role in guiding further clinical management.

Clinical & Coding Specifications

Clinical Context

A patient presents to the office with a lesion, swelling, or abnormal tissue on the lip. The provider, typically an otolaryngologist, oral & maxillofacial surgeon, or allergy & immunology physician, evaluates the area and determines that a biopsy is necessary to establish a diagnosis. The procedure involves excising a small sample of lip tissue for pathological examination. This workflow is common for patients with suspected neoplastic, inflammatory, or other abnormal conditions affecting the lips.

Coding Specifications

Modifiers:
- Modifier 51: Used when multiple procedures are performed during the same session. Indicates that more than one surgical procedure was carried out.
- Modifier 59: Used to denote a distinct procedural service, indicating that the biopsy of the lip is separate from other procedures performed on the same day.
Provider Taxonomies:

Taxonomy Code	Specialty
`207Y00000X`

National Reimbursement Benchmarks

For CPT code 40490, the national mean rate for Medicare is $124.39, while the BUCA (average commercial) mean rate is $138.08. Commercial payers such as UnitedHealth Group and Cigna have notably higher mean rates, with UnitedHealth Group at $188.21 and Cigna at $166.43, compared to Medicare.

Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Medicare shows the tightest range at $13.00, indicating less variability in rates. In contrast, UnitedHealth Group has the widest range at $106.00, reflecting significant rate variation. Cigna and Blue Cross Blue Shield also exhibit broad ranges, at $90.50 and $57.62 respectively.

The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.

State Benchmarks

State: Alaska1 / 50

Alaska Benchmarks

Alaska exhibits a substantial spread in reimbursement rates for CPT code 40490, with Blue Cross Blue Shield showing a rate range from $216.00 at the 25th percentile to $351.00 at the 75th percentile, and Cigna ranging from $128.00 to $287.75. Aetna, however, displays a flat rate structure, with all percentiles at $503.00, indicating no variability. Compared to national averages, Alaska's commercial payers consistently offer higher mean rates, with Aetna's mean rate in Alaska ($435.33) far exceeding its national mean ($109.32). Medicare's mean rate in Alaska ($120.51) is slightly below the national mean ($124.39).

The table and chart below present the full breakdown of payer-specific reimbursement rates for CPT code 40490 in Alaska, highlighting the differences in mean rates and percentile spreads across the major payers.

Key Insights for Alaska

Aetna is the highest paying payer for CPT 40490 in Alaska, with a mean rate of $435.33, while Medicare is the lowest at $120.51.
All commercial payers in Alaska reimburse at rates significantly above their respective national averages, with Aetna's mean rate nearly four times the national mean.
The rate spread is widest for Aetna ($503 - $503 = $0), indicating a flat rate, while Blue Cross Blue Shield and Cigna show more variability in their percentiles.

CPT 40520: V-shaped Lip Excision with Primary Linear Closure

CPT-40527-LIP-EXCISION-FULL-THICKNESS-WITH-FLAP-RECONSTRUCTION

CPT 40527: Full-Thickness Lip Excision with Flap Reconstruction

CPT-40510-LIP-WEDGE-EXCISION-CLOSURE

CPT 40510: Lip Wedge Excision with Simple Closure

CPT-40500-VERMILION-BORDER-EXCISION-LIP-LESION

CPT 40500: Excision of Growth From Vermilion Border, Lip

CPT-40530-LIP-EXCISION-MORE-THAN-ONE-FOURTH-NO-RECONSTRUCTION

CPT 40530: Excision of More Than One Fourth of Lip Without Reconstruction

CPT-40525-LIP-EXCISION-FULL-THICKNESS-WITH-LOCAL-FLAP-CLOSURE

CPT 40525: Full-Thickness Lip Excision with Local Flap Closure

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.